Retrovirus Testing Market Size, Share, Trends, Growth and Forecast 2028

Retrovirus Testing Market

Retrovirus Testing Market By Test Type (Infectivity Assay, Product-Enhanced Reverse Transcriptase (PERT) Assay, Co-Cultivation Assay, Transmission Electron Microscopy, Radio-Immune Assay, Western Blot Analysis, Immunofluorescence, Serological Tests), By Technique Type (High-Throughput Screening, Enzyme-Linked Immuno-Sorbent Assay (ELISA), Polymerase Chain Reaction (PCR)), By Sample Type (Blood, Serum, Body Fluids, Cells), By End-User (Hospitals, Clinics, Diagnostic Laboratories & Centers), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 - 2028-

Category: Healthcare Report Format : PDF Pages: 254 Report Code: ZMR-2403 Published Date: Aug-2022 Status : Published
Market Size in 2021 Market Forecast in 2028 CAGR (in %) Base Year
USD 182.4 Million USD 456.1 Million 16.5% 2021

Table Of Content

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Retrovirus Testing Market, (2022 - 2028) (USD Million)
    • 2.2 Global Retrovirus Testing Market : snapshot
  • Chapter 3. Global Retrovirus Testing Market - Industry Analysis
    • 3.1 Retrovirus Testing Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Rising government initiatives to increase the number of retrovirus tests to drive market growth
    • 3.3 Market Restraints
      • 3.3.1. The lack of skilled professionals to perform the assays and the high cost of retrovirus testing kits hinder the market growth
    • 3.4 Market Opportunities
    • 3.5 Market Challenges
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Test Type
      • 3.7.2 Market attractiveness analysis By Technique Type
      • 3.7.3 Market attractiveness analysis By Sample Type
      • 3.7.4 Market attractiveness analysis By End User
  • Chapter 4. Global Retrovirus Testing Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Retrovirus Testing Market: company market share, 2021
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Retrovirus Testing Market - Test Type Analysis
    • 5.1 Global Retrovirus Testing Market overview: By Test Type
      • 5.1.1 Global Retrovirus Testing Market share, By Test Type, 2021 and 2028
    • 5.2 Infectivity Assay
      • 5.2.1 Global Retrovirus Testing Market by Infectivity Assay, 2022 - 2028 (USD Million)
    • 5.3 Product-Enhanced Reverse Transcriptase (PERT) Assay
      • 5.3.1 Global Retrovirus Testing Market by Product-Enhanced Reverse Transcriptase (PERT) Assay, 2022 - 2028 (USD Million)
    • 5.4 Co-Cultivation Assay
      • 5.4.1 Global Retrovirus Testing Market by Co-Cultivation Assay, 2022 - 2028 (USD Million)
    • 5.5 Transmission Electron Microscopy
      • 5.5.1 Global Retrovirus Testing Market by Transmission Electron Microscopy, 2022 - 2028 (USD Million)
    • 5.6 Radio-Immune Assay
      • 5.6.1 Global Retrovirus Testing Market by Radio-Immune Assay, 2022 - 2028 (USD Million)
    • 5.7 Western Blot Analysis
      • 5.7.1 Global Retrovirus Testing Market by Western Blot Analysis, 2022 - 2028 (USD Million)
    • 5.8 Immunofluorescence
      • 5.8.1 Global Retrovirus Testing Market by Immunofluorescence, 2022 - 2028 (USD Million)
    • 5.9 Serological Tests
      • 5.9.1 Global Retrovirus Testing Market by Serological Tests, 2022 - 2028 (USD Million)
  • Chapter 6. Global Retrovirus Testing Market - Technique Type Analysis
    • 6.1 Global Retrovirus Testing Market overview: By Technique Type
      • 6.1.1 Global Retrovirus Testing Market share, By Technique Type, 2021 and 2028
    • 6.2 High-Throughput Screening
      • 6.2.1 Global Retrovirus Testing Market by High-Throughput Screening, 2022 - 2028 (USD Million)
    • 6.3 Enzyme Linked Immuno-Sorbent Assay (ELISA)
      • 6.3.1 Global Retrovirus Testing Market by Enzyme Linked Immuno-Sorbent Assay (ELISA), 2022 - 2028 (USD Million)
    • 6.4 Polymerase Chain Reaction (PCR)
      • 6.4.1 Global Retrovirus Testing Market by Polymerase Chain Reaction (PCR), 2022 - 2028 (USD Million)
  • Chapter 7. Global Retrovirus Testing Market - Sample Type Analysis
    • 7.1 Global Retrovirus Testing Market overview: By Sample Type
      • 7.1.1 Global Retrovirus Testing Market share, By Sample Type, 2021 and 2028
    • 7.2 Blood
      • 7.2.1 Global Retrovirus Testing Market by Blood, 2022 - 2028 (USD Million)
    • 7.3 Serum
      • 7.3.1 Global Retrovirus Testing Market by Serum, 2022 - 2028 (USD Million)
    • 7.4 Body Fluids
      • 7.4.1 Global Retrovirus Testing Market by Body Fluids, 2022 - 2028 (USD Million)
    • 7.5 Cells
      • 7.5.1 Global Retrovirus Testing Market by Cells, 2022 - 2028 (USD Million)
  • Chapter 8. Global Retrovirus Testing Market - End User Analysis
    • 8.1 Global Retrovirus Testing Market overview: By End User
      • 8.1.1 Global Retrovirus Testing Market share, By End User, 2021 and 2028
    • 8.2 Hospitals
      • 8.2.1 Global Retrovirus Testing Market by Hospitals, 2022 - 2028 (USD Million)
    • 8.3 Clinics
      • 8.3.1 Global Retrovirus Testing Market by Clinics, 2022 - 2028 (USD Million)
    • 8.4 Diagnostic Laboratories & Centers
      • 8.4.1 Global Retrovirus Testing Market by Diagnostic Laboratories & Centers, 2022 - 2028 (USD Million)
  • Chapter 9. Retrovirus Testing Market - Regional Analysis
    • 9.1 Global Retrovirus Testing Market Regional Overview
    • 9.2 Global Retrovirus Testing Market Share, by Region, 2021 & 2028 (USD Million)
    • 9.3. North America
      • 9.3.1 North America Retrovirus Testing Market, 2022 - 2028 (USD Million)
        • 9.3.1.1 North America Retrovirus Testing Market, by Country, 2022 - 2028 (USD Million)
    • 9.4 North America Retrovirus Testing Market, by Test Type, 2022 - 2028
      • 9.4.1 North America Retrovirus Testing Market, by Test Type, 2022 - 2028 (USD Million)
    • 9.5 North America Retrovirus Testing Market, by Technique Type, 2022 - 2028
      • 9.5.1 North America Retrovirus Testing Market, by Technique Type, 2022 - 2028 (USD Million)
    • 9.6 North America Retrovirus Testing Market, by Sample Type, 2022 - 2028
      • 9.6.1 North America Retrovirus Testing Market, by Sample Type, 2022 - 2028 (USD Million)
    • 9.7 North America Retrovirus Testing Market, by End User, 2022 - 2028
      • 9.7.1 North America Retrovirus Testing Market, by End User, 2022 - 2028 (USD Million)
    • 9.4. Europe
      • 9.4.2 Europe Retrovirus Testing Market, 2022 - 2028 (USD Million)
        • 9.4.2.1 Europe Retrovirus Testing Market, by Country, 2022 - 2028 (USD Million)
    • 9.4 Europe Retrovirus Testing Market, by Test Type, 2022 - 2028
      • 9.4.1 Europe Retrovirus Testing Market, by Test Type, 2022 - 2028 (USD Million)
    • 9.5 Europe Retrovirus Testing Market, by Technique Type, 2022 - 2028
      • 9.5.1 Europe Retrovirus Testing Market, by Technique Type, 2022 - 2028 (USD Million)
    • 9.6 Europe Retrovirus Testing Market, by Sample Type, 2022 - 2028
      • 9.6.1 Europe Retrovirus Testing Market, by Sample Type, 2022 - 2028 (USD Million)
    • 9.7 Europe Retrovirus Testing Market, by End User, 2022 - 2028
      • 9.7.1 Europe Retrovirus Testing Market, by End User, 2022 - 2028 (USD Million)
    • 9.5. Asia Pacific
      • 9.5.3 Asia Pacific Retrovirus Testing Market, 2022 - 2028 (USD Million)
        • 9.5.3.1 Asia Pacific Retrovirus Testing Market, by Country, 2022 - 2028 (USD Million)
    • 9.4 Asia Pacific Retrovirus Testing Market, by Test Type, 2022 - 2028
      • 9.4.1 Asia Pacific Retrovirus Testing Market, by Test Type, 2022 - 2028 (USD Million)
    • 9.5 Asia Pacific Retrovirus Testing Market, by Technique Type, 2022 - 2028
      • 9.5.1 Asia Pacific Retrovirus Testing Market, by Technique Type, 2022 - 2028 (USD Million)
    • 9.6 Asia Pacific Retrovirus Testing Market, by Sample Type, 2022 - 2028
      • 9.6.1 Asia Pacific Retrovirus Testing Market, by Sample Type, 2022 - 2028 (USD Million)
    • 9.7 Asia Pacific Retrovirus Testing Market, by End User, 2022 - 2028
      • 9.7.1 Asia Pacific Retrovirus Testing Market, by End User, 2022 - 2028 (USD Million)
    • 9.6. Latin America
      • 9.6.4 Latin America Retrovirus Testing Market, 2022 - 2028 (USD Million)
        • 9.6.4.1 Latin America Retrovirus Testing Market, by Country, 2022 - 2028 (USD Million)
    • 9.4 Latin America Retrovirus Testing Market, by Test Type, 2022 - 2028
      • 9.4.1 Latin America Retrovirus Testing Market, by Test Type, 2022 - 2028 (USD Million)
    • 9.5 Latin America Retrovirus Testing Market, by Technique Type, 2022 - 2028
      • 9.5.1 Latin America Retrovirus Testing Market, by Technique Type, 2022 - 2028 (USD Million)
    • 9.6 Latin America Retrovirus Testing Market, by Sample Type, 2022 - 2028
      • 9.6.1 Latin America Retrovirus Testing Market, by Sample Type, 2022 - 2028 (USD Million)
    • 9.7 Latin America Retrovirus Testing Market, by End User, 2022 - 2028
      • 9.7.1 Latin America Retrovirus Testing Market, by End User, 2022 - 2028 (USD Million)
    • 9.7. The Middle-East and Africa
      • 9.7.5 The Middle-East and Africa Retrovirus Testing Market, 2022 - 2028 (USD Million)
        • 9.7.5.1 The Middle-East and Africa Retrovirus Testing Market, by Country, 2022 - 2028 (USD Million)
    • 9.4 The Middle-East and Africa Retrovirus Testing Market, by Test Type, 2022 - 2028
      • 9.4.1 The Middle-East and Africa Retrovirus Testing Market, by Test Type, 2022 - 2028 (USD Million)
    • 9.5 The Middle-East and Africa Retrovirus Testing Market, by Technique Type, 2022 - 2028
      • 9.5.1 The Middle-East and Africa Retrovirus Testing Market, by Technique Type, 2022 - 2028 (USD Million)
    • 9.6 The Middle-East and Africa Retrovirus Testing Market, by Sample Type, 2022 - 2028
      • 9.6.1 The Middle-East and Africa Retrovirus Testing Market, by Sample Type, 2022 - 2028 (USD Million)
    • 9.7 The Middle-East and Africa Retrovirus Testing Market, by End User, 2022 - 2028
      • 9.7.1 The Middle-East and Africa Retrovirus Testing Market, by End User, 2022 - 2028 (USD Million)
  • Chapter 10. Company Profiles
    • 10.1 BGI Genomics
      • 10.1.1 Overview
      • 10.1.2 Financials
      • 10.1.3 Product Portfolio
      • 10.1.4 Business Strategy
      • 10.1.5 Recent Developments
    • 10.2 Abbott Diagnostics
      • 10.2.1 Overview
      • 10.2.2 Financials
      • 10.2.3 Product Portfolio
      • 10.2.4 Business Strategy
      • 10.2.5 Recent Developments
    • 10.3 Alere Inc
      • 10.3.1 Overview
      • 10.3.2 Financials
      • 10.3.3 Product Portfolio
      • 10.3.4 Business Strategy
      • 10.3.5 Recent Developments
    • 10.4 Hybribio Biotech
      • 10.4.1 Overview
      • 10.4.2 Financials
      • 10.4.3 Product Portfolio
      • 10.4.4 Business Strategy
      • 10.4.5 Recent Developments
    • 10.5 Roche Diagnostics Ltd
      • 10.5.1 Overview
      • 10.5.2 Financials
      • 10.5.3 Product Portfolio
      • 10.5.4 Business Strategy
      • 10.5.5 Recent Developments
    • 10.6 Tellgen Corporation
      • 10.6.1 Overview
      • 10.6.2 Financials
      • 10.6.3 Product Portfolio
      • 10.6.4 Business Strategy
      • 10.6.5 Recent Developments
    • 10.7 DiaSorin S.p.A.
      • 10.7.1 Overview
      • 10.7.2 Financials
      • 10.7.3 Product Portfolio
      • 10.7.4 Business Strategy
      • 10.7.5 Recent Developments
    • 10.8 Dian Diagnostics
      • 10.8.1 Overview
      • 10.8.2 Financials
      • 10.8.3 Product Portfolio
      • 10.8.4 Business Strategy
      • 10.8.5 Recent Developments
    • 10.9 bioMerieux SA
      • 10.9.1 Overview
      • 10.9.2 Financials
      • 10.9.3 Product Portfolio
      • 10.9.4 Business Strategy
      • 10.9.5 Recent Developments
    • 10.10 Becton
      • 10.10.1 Overview
      • 10.10.2 Financials
      • 10.10.3 Product Portfolio
      • 10.10.4 Business Strategy
      • 10.10.5 Recent Developments
    • 10.11 Dickinson & Company
      • 10.11.1 Overview
      • 10.11.2 Financials
      • 10.11.3 Product Portfolio
      • 10.11.4 Business Strategy
      • 10.11.5 Recent Developments
    • 10.12 Xilong Scientific
      • 10.12.1 Overview
      • 10.12.2 Financials
      • 10.12.3 Product Portfolio
      • 10.12.4 Business Strategy
      • 10.12.5 Recent Developments

Table Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global Retrovirus Testing Market, 2022 - 2028 (USD Million)
  • 4. Porter’s Five Forces Analysis
  • 5. Global Retrovirus Testing Market attractiveness, By Test Type
  • 6. Global Retrovirus Testing Market attractiveness, By Technique Type
  • 7. Global Retrovirus Testing Market attractiveness, By Sample Type
  • 8. Global Retrovirus Testing Market attractiveness, By End User
  • 9. Global Retrovirus Testing Market share by Test Type, 2022 and 2028 (USD Million)
  • 10. Global Retrovirus Testing Market by Infectivity Assay, 2022 - 2028 (USD Million)
  • 11. Global Retrovirus Testing Market by Product-Enhanced Reverse Transcriptase (PERT) Assay, 2022 - 2028 (USD Million)
  • 12. Global Retrovirus Testing Market by Co-Cultivation Assay, 2022 - 2028 (USD Million)
  • 13. Global Retrovirus Testing Market by Transmission Electron Microscopy, 2022 - 2028 (USD Million)
  • 14. Global Retrovirus Testing Market by Radio-Immune Assay, 2022 - 2028 (USD Million)
  • 15. Global Retrovirus Testing Market by Western Blot Analysis, 2022 - 2028 (USD Million)
  • 16. Global Retrovirus Testing Market by Immunofluorescence, 2022 - 2028 (USD Million)
  • 17. Global Retrovirus Testing Market by Serological Tests, 2022 - 2028 (USD Million)
  • 18. Global Retrovirus Testing Market share by Technique Type, 2022 and 2028 (USD Million)
  • 19. Global Retrovirus Testing Market by High-Throughput Screening, 2022 - 2028 (USD Million)
  • 20. Global Retrovirus Testing Market by Enzyme Linked Immuno-Sorbent Assay (ELISA), 2022 - 2028 (USD Million)
  • 21. Global Retrovirus Testing Market by Polymerase Chain Reaction (PCR), 2022 - 2028 (USD Million)
  • 22. Global Retrovirus Testing Market share by Sample Type, 2022 and 2028 (USD Million)
  • 23. Global Retrovirus Testing Market by Blood, 2022 - 2028 (USD Million)
  • 24. Global Retrovirus Testing Market by Serum, 2022 - 2028 (USD Million)
  • 25. Global Retrovirus Testing Market by Body Fluids, 2022 - 2028 (USD Million)
  • 26. Global Retrovirus Testing Market by Cells, 2022 - 2028 (USD Million)
  • 27. Global Retrovirus Testing Market share by End User, 2022 and 2028 (USD Million)
  • 28. Global Retrovirus Testing Market by Hospitals, 2022 - 2028 (USD Million)
  • 29. Global Retrovirus Testing Market by Clinics, 2022 - 2028 (USD Million)
  • 30. Global Retrovirus Testing Market by Diagnostic Laboratories & Centers, 2022 - 2028 (USD Million)
  • 31. Global Retrovirus Testing Market share, by Region, 2022 and 2028
  • 32. North America Retrovirus Testing Market, 2022 - 2028 (USD Million)
  • 33. Europe Retrovirus Testing Market, 2022 - 2028 (USD Million)
  • 34. Asia Pacific Retrovirus Testing Market, 2022 - 2028 (USD Million)
  • 35. Latin America Retrovirus Testing Market, 2022 - 2028 (USD Million)
  • 36. The Middle-East and Africa Retrovirus Testing Market, 2022 - 2028 (USD Million)

Table Of Tables

  • 1. Global Retrovirus Testing Market: Snapshot
  • 2. Drivers of the Retrovirus Testing Market: impact analysis
  • 3. North America Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 4. North America Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 5. North America Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 6. North America Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 7. U.S. Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 8. U.S. Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 9. U.S. Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 10. U.S. Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 11. Canada Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 12. Canada Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 13. Canada Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 14. Canada Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 15. Europe Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 16. Europe Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 17. Europe Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 18. Europe Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 19. Germany Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 20. Germany Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 21. Germany Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 22. Germany Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 23. France Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 24. France Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 25. France Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 26. France Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 27. U.K. Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 28. U.K. Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 29. U.K. Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 30. U.K. Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 31. Italy Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 32. Italy Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 33. Italy Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 34. Italy Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 35. Spain Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 36. Spain Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 37. Spain Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 38. Spain Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 39. Rest of Europe Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 40. Rest of Europe Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 41. Rest of Europe Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 42. Rest of Europe Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 43. Asia Pacific Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 44. Asia Pacific Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 45. Asia Pacific Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 46. Asia Pacific Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 47. China Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 48. China Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 49. China Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 50. China Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 51. Japan Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 52. Japan Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 53. Japan Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 54. Japan Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 55. India Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 56. India Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 57. India Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 58. India Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 59. South Korea Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 60. South Korea Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 61. South Korea Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 62. South Korea Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 63. South-East Asia Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 64. South-East Asia Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 65. South-East Asia Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 66. South-East Asia Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 67. Rest of Asia Pacific Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 68. Rest of Asia Pacific Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 69. Rest of Asia Pacific Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 70. Rest of Asia Pacific Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 71. Latin America Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 72. Latin America Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 73. Latin America Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 74. Latin America Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 75. Brazil Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 76. Brazil Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 77. Brazil Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 78. Brazil Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 79. Mexico Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 80. Mexico Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 81. Mexico Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 82. Mexico Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 83. Rest of Latin America Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 84. Rest of Latin America Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 85. Rest of Latin America Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 86. Rest of Latin America Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 87. The Middle-East and Africa Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 88. The Middle-East and Africa Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 89. The Middle-East and Africa Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 90. The Middle-East and Africa Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 91. GCC Countries Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 92. GCC Countries Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 93. GCC Countries Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 94. GCC Countries Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 95. South Africa Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 96. South Africa Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 97. South Africa Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 98. South Africa Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)
  • 99. Rest of Middle-East Africa Retrovirus Testing Market revenue, By Test Type, 2022 - 2028 (USD Million)
  • 100. Rest of Middle-East Africa Retrovirus Testing Market revenue, By Technique Type, 2022 - 2028 (USD Million)
  • 101. Rest of Middle-East Africa Retrovirus Testing Market revenue, By Sample Type, 2022 - 2028 (USD Million)
  • 102. Rest of Middle-East Africa Retrovirus Testing Market revenue, By End User, 2022 - 2028 (USD Million)

Methodology

FrequentlyAsked Questions

Adoption of in-vitro assay methods for retrovirus diagnosis is increasing due to an increase in the incidence of sexually transmissible diseases, as is an investment in research and development, boosting the global retrovirus testing market. The introduction of rapid and technologically sophisticated methods for detecting retroviral infections, rising awareness of diagnostic tests, and rising costs associated with retrovirus screening are anticipated to drive the global market for retrovirus testing during the forecast period.

According to the report, the global retrovirus testing market size was worth USD 182.4 million in 2021 and is estimated to grow to USD 456.1 million by 2028, with a compound annual growth rate (CAGR) of approximately 16.5 percent during the forecast period.

North America is anticipated to continue leading the retrovirus testing market throughout the projected period. The key factors driving the regional market growth are increased awareness about retrovirus diagnosis, well-established healthcare infrastructure, and increased research and development activities investments. Moreover, according to HIV.gov statistics published in June 2021, nearly 2 million individuals in the United States have HIV. This suggests that the prevalence of HIV in the nation is high, which will increase demand for its diagnosing products and further propel the regional market.

Some of the main competitors dominating the global retrovirus testing market include - BGI Genomics, Abbott Diagnostics, Alere Inc, Hybribio Biotech, Roche Diagnostics Ltd, Tellgen Corporation, DiaSorin S.p.A., Dian Diagnostics, bioMerieux SA, Becton, Dickinson & Company, Xilong Scientific.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed